Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Stasi

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
European Journal of Haematology|August 10, 2013
Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trialsFrancesco Rodeghiero, Roberto Stasi, Aristoteles Giagounidis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Primary gastric plasmacytoma and Helicobacter pylori infectionRoberto Stasi, Maria Laura Evangelista, Maurizio Brunetti, et al.
British Journal of Haematology|August 8, 2015
Mycophenolate mofetil therapy for severe immune thrombocytopeniaAlice Taylor, Lucy Neave, Shalini Solanki, et al.
Blood|November 8, 2007
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemiaCarlo Visco, Marco Ruggeri, Maria Laura Evangelista, et al.
Blood|October 24, 2008
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic reviewRoberto Stasi, Ameet Sarpatwari, Jodi B Segal, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 2, 2005
Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: analysis of factors affecting the achievement of tumor necrosisClaudio Maurizio Pacella, Giancarlo Bizzarri, Giampiero Francica, et al.
Journal of Hepatology|March 21, 2006
Analysis of factors predicting survival in patients with hepatocellular carcinoma treated with percutaneous laser ablationClaudio Maurizio Pacella, Giancarlo Bizzarri, Giampiero Francica, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysisClaudio Maurizio Pacella, Giampiero Francica, Francesca Marta Lilja Di Lascio, et al.
Haematologica|November 13, 2012
Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 yearsNicola Vianelli, Francesca Palandri, Nicola Polverelli, et al.
British Journal of Haematology|March 17, 2010
Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19)Sergio Amadori, Stefan Suciu, Dominik Selleslag, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
European Journal of Haematology|August 10, 2013
Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trialsFrancesco Rodeghiero, Roberto Stasi, Aristoteles Giagounidis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Primary gastric plasmacytoma and Helicobacter pylori infectionRoberto Stasi, Maria Laura Evangelista, Maurizio Brunetti, et al.
British Journal of Haematology|August 8, 2015
Mycophenolate mofetil therapy for severe immune thrombocytopeniaAlice Taylor, Lucy Neave, Shalini Solanki, et al.
Blood|November 8, 2007
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemiaCarlo Visco, Marco Ruggeri, Maria Laura Evangelista, et al.
Blood|October 24, 2008
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic reviewRoberto Stasi, Ameet Sarpatwari, Jodi B Segal, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 2, 2005
Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: analysis of factors affecting the achievement of tumor necrosisClaudio Maurizio Pacella, Giancarlo Bizzarri, Giampiero Francica, et al.
Journal of Hepatology|March 21, 2006
Analysis of factors predicting survival in patients with hepatocellular carcinoma treated with percutaneous laser ablationClaudio Maurizio Pacella, Giancarlo Bizzarri, Giampiero Francica, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysisClaudio Maurizio Pacella, Giampiero Francica, Francesca Marta Lilja Di Lascio, et al.
Haematologica|November 13, 2012
Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 yearsNicola Vianelli, Francesca Palandri, Nicola Polverelli, et al.
British Journal of Haematology|March 17, 2010
Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19)Sergio Amadori, Stefan Suciu, Dominik Selleslag, et al.
Pageof 9